| Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms R Abeti, A Zeitlberger, C Peelo, H Fassihi, RPE Sarkany, AR Lehmann, ... British Journal of Pharmacology 176 (22), 4293-4301, 2019 | 32 | 2019 |
| The reading the mind in the eyes test short form (A & B): Validation and outcomes in an amyotrophic lateral sclerosis cohort T Burke, M Pinto-Grau, E Costello, C Peelo, K Lonergan, M Heverin, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21 (5-6), 380-388, 2020 | 10 | 2020 |
| Functional network dynamics revealed by EEG microstates reflect cognitive decline in amyotrophic lateral sclerosis M Metzger, S Dukic, R McMackin, E Giglia, M Mitchell, S Bista, E Costello, ... Human Brain Mapping 45 (1), e26536, 2024 | 2 | 2024 |
| Epidemiologic Trends of Amyotrophic Lateral Sclerosis in Ireland, 1996–2021 R McFarlane, C Peelo, M Galvin, M Heverin, O Hardiman Neurology 101 (19), e1905-e1912, 2023 | 2 | 2023 |
| Distinct longitudinal changes in EEG measures reflecting functional network disruption in ALS cognitive phenotypes M Metzger, S Dukic, R McMackin, E Giglia, M Mitchell, S Bista, E Costello, ... | | 2024 |
| H37 Validating the Edinburgh cognitive and behavioural als screen (ECAS) as a screening measure of cognitive impairment in pre-manifesting huntington’s disease M Fallon, S Abrahams, D Campbell, E Cleary, M Hammond, O Hardiman, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (Suppl 1), A75-A76, 2022 | | 2022 |
| F32 Apathy in three dimensions: incidence and neurospychological correlates of apathy in HD CG Peelo, M Fallon, D Campbell, M Hammond, O Hardiman, N Pender Journal of Neurology, Neurosurgery & Psychiatry 93 (Suppl 1), A47-A47, 2022 | | 2022 |
| Abnormal microstate resting-state EEG characteristics in Amyotrophic lateral sclerosis M Metzger, S Dukic, R McMackin, E Giglia, M Mitchell, S Bista, C Peelo, ... | | |
